MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 59 filers reported holding MENLO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $614,000 | +30.9% | 354,989 | +102.8% | 0.00% | – |
| Q1 2020 | $469,000 | +46.6% | 175,037 | +153.1% | 0.00% | – |
| Q4 2019 | $320,000 | +3.6% | 69,169 | 0.0% | 0.00% | – |
| Q3 2019 | $309,000 | -0.6% | 69,169 | +33.5% | 0.00% | – |
| Q2 2019 | $311,000 | +1.0% | 51,798 | +32.0% | 0.00% | – |
| Q1 2019 | $308,000 | +93.7% | 39,236 | +1.5% | 0.00% | – |
| Q4 2018 | $159,000 | -36.9% | 38,662 | +51.0% | 0.00% | – |
| Q3 2018 | $252,000 | +48.2% | 25,598 | +22.3% | 0.00% | – |
| Q2 2018 | $170,000 | -75.1% | 20,931 | +15.2% | 0.00% | – |
| Q1 2018 | $682,000 | – | 18,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners L.P. | 1,461,552 | $11,868,000 | 12.24% |
| Vivo Capital, LLC | 4,011,236 | $32,571,000 | 4.20% |
| DAFNA Capital Management LLC | 312,000 | $2,533,000 | 1.19% |
| Novo Holdings A/S | 1,436,313 | $11,663,000 | 1.17% |
| Perceptive Advisors | 1,241,287 | $10,079,000 | 0.26% |
| Rock Springs Capital Management LP | 330,000 | $2,680,000 | 0.10% |
| Baker Brothers Advisors | 700,000 | $5,684,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 50,000 | $406,000 | 0.02% |
| A.R.T. Advisors, LLC | 31,703 | $257,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 2,036,111 | $16,533,000 | 0.01% |